Filing Details

Accession Number:
0000950170-24-131665
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-11-27 19:39:26
Reporting Period:
2024-11-26
Accepted Time:
2024-11-27 19:39:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1661460 Poseida Therapeutics Inc. PSTX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1373110 J Mark Gergen C/O Poseida Therapeutics, Inc.
9390 Towne Center Drive Suite 200
San Diego CA 92121
Executive Chairman No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-11-26 30,000 $2.78 681,291 No 4 M Direct
Common Stock Disposition 2024-11-26 30,000 $9.27 651,291 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2024-11-26 30,000 $0.00 30,000 $2.78
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
126,372 2028-03-01 No 4 M Direct
Footnotes
  1. The option exercise and sale reported in this Form 4 were effected pusuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 21, 2024.
  2. The stock option is fully vested and exerciseable.